Currently, ORIC Pharmaceuticals Inc [ORIC] is trading at $11.71, down -2.42%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The ORIC shares have gain 11.95% over the last week, with a monthly amount glided 12.81%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Ladenburg Thalmann started tracking the stock with Buy rating on July 08, 2025, and set its price target to $15. On October 31, 2024, Wells Fargo initiated with an Overweight rating and assigned a price target of $20 on the stock. Stifel started tracking the stock assigning a Buy rating and suggested a price target of $20 on September 06, 2024. Cantor Fitzgerald initiated its recommendation with an Overweight. Wedbush started tracking with an Outperform rating for this stock on September 22, 2023, and assigned it a price target of $8. In a note dated March 23, 2023, H.C. Wainwright upgraded a Buy rating on this stock but restated the target price of $16.
This stock has fluctuated between a low of $3.90 and a high of $14.67 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $15 within the next 12 months. ORIC Pharmaceuticals Inc [NASDAQ: ORIC] shares were valued at $11.71 at the most recent close of the market. An investor can expect a potential return of 28.1% based on the average ORIC price forecast.
Analyzing the ORIC fundamentals
Gross Profit Margin for this corporation currently stands at -0.33% with Operating Profit Margin at -140.4%, Pretax Profit Margin comes in at -128.75%, and Net Profit Margin reading is -128.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.4, Equity is -0.52 and Total Capital is -0.46.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.52 points at the first support level, and at 11.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.01, and for the 2nd resistance point, it is at 12.32.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ORIC Pharmaceuticals Inc [NASDAQ:ORIC] is 16.13. In addition, the Quick Ratio stands at 16.13 and the Cash Ratio stands at 4.2.
Transactions by insiders
Recent insider trading involved Chacko Jacob, PRESIDENT AND CEO, that happened on Sep 22 ’25 when 0.12 million shares were sold. Director, Jacob Chacko completed a deal on Sep 22 ’25 to buy 0.25 million shares. Meanwhile, Chief Financial Officer Piscitelli Dominic sold 20000.0 shares on Jul 01 ’25.
